FDLI Commitment to Diversity & Inclusion

FDLI Policy for Commitment to Diversity and Inclusion

As a membership organization, FDLI is committed to supporting, promoting, and celebrating diversity, equity and inclusion in the food and drug law profession. In order to fulfill this key aspect of our mission and core values as an organization, the FDLI Board of Directors affirms that all members and professionals within the field, whatever their race, religion, ethnicity, gender, gender identity or expression, national origin, genetics, age, sexual orientation, or disability, are valued, respected, and included in our community. We seek to address inequities not only within FDLI’s organizational positions, including member committee leadership/membership, speaking and author roles, and staff, but also in the pipeline of emerging food and drug law professionals in our work with graduate schools, law schools, and students.

Adopted by the FDLI Board of Directors, Sept. 9, 2020.

Black Lives Matter Advisory Group

Elizabeth H. Anderson, Anderson & Associates, LLC
Oluwaseun (Kemi) Asante, FDA – CDER
Shamina Aubuchon
, Altria Client Services LLC
Alundai Benjamin, University of Connecticut
Jennifer Bragg, Skadden, Arps, Slate, Meagher & Flom LLP, and Chair, FDLI Board of Directors
John Claud, DOJ
Noni L. Ellison, Carestream Dental LLC
Donna Gallien, FDA – ORA
Iris Gibbs, Karyopharm Therapeutics
Sandra Cohen Kalter, Medtronic, and Member, FDLI Board of Directors
Melanie Katrice Gross, Greentech, Inc.
Janet Johnson, Terumo BCT, Inc.
Dan Kracov, Arnold & Porter LLP, and Vice Chair, FDLI Board of Directors
Anthony Lee, FDA – CFSAN
Valerie B. Marshall, FDA – CBER
Flora Chinyere Okereke, RAI Service Company (RAISC)
Sarah Thompson Schick, DLA Piper LLP (US)
LieAnn Van-Tull, Keller and Heckman LLP
Jeffrey N. Wasserstein, Hyman, Phelps & McNamara, PC
John (Barr) Weiner, FDA – OC
Patti Zettler, The Ohio State University